Pear Therapeutics Joins Epic App Orchard to Enable Clinicians to Monitor Prescription Digital Therapeutics

By AIT News Desk On Mar 28, 2022

***PearConnect* *platform for prescription digital therapeutics (PDTs) is now available for providers in the Epic App Orchard Gallery***

Pear Therapeutics, Inc. , the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced its PearConnect platform is available to healthcare providers in the Epic App Orchard Gallery. Initially, this will allow healthcare providers who implement the application the ability to access the PearConnect platform within Epic’s leading electronic health record (EHR) platform to remotely monitor patients who have been prescribed Pear’s FDA-authorized PDTs reSET and reSET-O for the treatment of substance use disorder and opioid use disorder, respectively.

Latest Aithority Insights : Data Society Recognized for Innovation in Data Science Training with 2022 Data Breakthrough Award, Product of the Year for Education

“We are excited to bring this opportunity to expand access to our PDTs, with the initial listing of our PearConnect platform in the App Orchard gallery to support reSET and reSET-O patients. We believe Pear’s integration with Epic will create a pathway for healthcare providers to easily access our PearConnect platform and enable scale to serve many more patients,” said Julia Strandberg, Chief Commercial Officer of Pear Therapeutics.

Browse The Complete News About Aithority: Microvast Launches New Li-ion Battery Cells and Next Generation Packs

By having the PearConnect platform in the App Orchard, Pear can provide seamless workflow integration for ease in managing patients who have been prescribed reSET or reSET-O, including patient progress review, and documenting interactions that qualify for available Current Procedural Terminology (CPT) codes such as Remote Therapeutic Monitoring (RTM). This will simplify access to Pear’s provider tool kit and allow clinicians to monitor PDTs. Additionally, clinicians don’t need to leave their workflow in Epic to access at-a-glance patient-generated data like lesson progress, cravings, and triggers.

Pear’s end-to-end platform discovers, develops, and delivers PDTs to patients and is intended to be scalable with the ability to host multiple PDTs developed by Pear and potentially by third parties. Pear’s development platform, PearCreate, is aimed toward the development of new PDT candidates, and Pear’s commercial platform, PearConnect, is aimed toward the commercialization of PDT products.

[To share your insights with us, please write to sghosh@martechseries.com]